Blood Res.  2018 Mar;53(1):92-94. 10.5045/br.2018.53.1.92.

A rare variant of t(17;19) in a case of Philadelphia positive adult acute lymphoblastic leukemia presenting with disseminated intravascular coagulation

• Safavi M
• Safaei A
• Lotfi M

• KMID: 2414374
• DOI: http://doi.org/10.5045/br.2018.53.1.92

Abstract

No abstract available.

MeSH Terms

Adult*
Disseminated Intravascular Coagulation*
Humans
Precursor Cell Lymphoblastic Leukemia-Lymphoma*

Figure

• 

  Fig. 1 Bone marrow karyotype exhibited t(17;19)(q11;p13) in addition to Philadelphia chromosome and unbalanced translocation between chromosomes 3 and 9.

Reference

1. Secker-Walker LM, Craig JM, Hawkins JM, Hoffbrand AV. Philadelphia positive acute lymphoblastic leukemia in adults: age distribution, BCR breakpoint and prognostic significance. Leukemia. 1991; 5:196–199. PMID: 2013979.

2. Ko BS, Tang JL, Lee FY, et al. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/ BCR-ABL-positive acute lymphoblastic leukemia in Taiwan. Am J Hematol. 2002; 71:291–299. PMID: 12447959.

3. Specchia G, Albano F, Anelli L, et al. Molecular cytogenetics characterization of a novel translocation involving chromosomes 17 and 19 in a Ph+ adult acute lymphoblastic leukaemia. Br J Haematol. 2002; 119:488–491. PMID: 12406090.

4. Moorman AV. The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia. Blood Rev. 2012; 26:123–135. PMID: 22436535.

5. Mullighan CG, Miller CB, Radtke I, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature. 2008; 453:110–114. PMID: 18408710.

6. Rieder H, Ludwig WD, Gassmann W, et al. Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia. Br J Haematol. 1996; 95:678–691. PMID: 8982045.

7. Druker BJ. Translation of the Philadelphia chromosome into therapy for CML. Blood. 2008; 112:4808–4817. PMID: 19064740.

8. Schultz KR, Bowman WP, Aledo A, et al. Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study. J Clin Oncol. 2009; 27:5175–5181. PMID: 19805687.

9. Harrison CJ, Martineau M, Secker-Walker LM. The Leukaemia Research Fund/United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia: a valuable resource for patient management. Br J Haematol. 2001; 113:3–10. PMID: 11328273.

10. Inaba T, Roberts WM, Shapiro LH, et al. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science. 1992; 257:531–534. PMID: 1386162.

11. Barbui T, Falanga A. Disseminated intravascular coagulation in acute leukemia. Semin Thromb Hemost. 2001; 27:593. PMID: 11740683.

12. Hunger SP, Devaraj PE, Foroni L, Secker-Walker LM, Cleary ML. Two types of genomic rearrangements create alternative E2A-HLF fusion proteins in t(17;19)-ALL. Blood. 1994; 83:2970–2977. PMID: 8180393.

13. Arana-Trejo RM, Cervantes-Peredo A, Rozen E, Kassack JJ, Gutiérrez M, Kofman-Alfaro S. Cytogenetic study of 22 adults and 3 children with acute lymphoblastic leukemia. Rev Invest Clin. 1993; 45:43–48. PMID: 8484065.

14. Minson KA, Prasad P, Vear S, et al. t(17;19) in children with acute lymphocytic leukemia: a report of 3 cases and a review of the literature. Case Rep Hematol. 2013; 2013:563291. PMID: 23346431.

15. Glover JM, Loriaux M, Tyner JW, Druker BJ, Chang BH. In vitro sensitivity to dasatinib in lymphoblasts from a patient with t(17;19)(q22;p13) gene rearrangement pre-B acute lymphoblastic leukemia. Pediatr Blood Cancer. 2012; 59:576–579. PMID: 22038978.